Mirum Pharmaceuticals, Inc. - Common Stock (MIRM)

CUSIP: 604749101

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Equity / Common Stock
Shares outstanding
51,400,915
Total 13F shares
21,451,984
Share change
-558,639
Total reported value
$425,174,000
Price per share
$19.82
Number of holders
60
Value change
-$8,433,468
Number of buys
30
Number of sells
35

Quarterly Holders Quick Answers

What is CUSIP 604749101?
CUSIP 604749101 identifies MIRM - Mirum Pharmaceuticals, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of MIRM - Mirum Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
NEA Management Company, LLC
13F
Company
8.1%
4,187,801
$73,119,000 31 Dec 2020
13F
FRAZIER MANAGEMENT LLC
13F
Company
6.9%
3,566,912
$62,278,000 31 Dec 2020
13F
DEERFIELD MANAGEMENT COMPANY, L.P.
13F
Company
6.7%
3,448,912
$60,218,000 31 Dec 2020
13F
Novo Holdings A/S
13F
Company
4.8%
2,445,147
$42,692,000 31 Dec 2020
13F
Rock Springs Capital Management LP
13F
Company
2.9%
1,496,525
$26,129,000 31 Dec 2020
13F
BAKER BROS. ADVISORS LP
13F
Company
1.3%
647,313
$11,302,000 31 Dec 2020
13F
VANGUARD GROUP INC
13F
Company
1.2%
627,796
$10,961,000 31 Dec 2020
13F
BlackRock Finance, Inc.
13F
Company
1.1%
554,889
$9,689,000 31 Dec 2020
13F
DRIEHAUS CAPITAL MANAGEMENT LLC
13F
Company
1.1%
544,341
$9,504,000 31 Dec 2020
13F
Sio Capital Management, LLC
13F
Company
0.96%
494,743
$8,638,000 31 Dec 2020
13F
Sofinnova Investments, Inc.
13F
Company
0.89%
454,974
$7,944,000 31 Dec 2020
13F
Boxer Capital, LLC
13F
Company
0.62%
317,000
$5,535,000 31 Dec 2020
13F
AXA S.A.
13F
Company
0.59%
305,486
$5,334,000 31 Dec 2020
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.54%
276,875
$4,834,000 31 Dec 2020
13F
AIGH Capital Management LLC
13F
Company
0.53%
274,583
$4,794,000 31 Dec 2020
13F
Burrage Capital Management LLC
13F
Company
0.31%
161,628
$2,822,000 31 Dec 2020
13F
FMR LLC
13F
Company
0.31%
159,228
$2,780,000 31 Dec 2020
13F
CVI Holdings, LLC
13F
Company
0.28%
142,035
$2,480,000 31 Dec 2020
13F
Ensign Peak Advisors, Inc
13F
Company
0.25%
126,393
$2,207,000 31 Dec 2020
13F
Monashee Investment Management LLC
13F
Company
0.24%
125,000
$2,183,000 31 Dec 2020
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.22%
112,212
$1,959,000 31 Dec 2020
13F
Maven Securities LTD
13F
Company
0.19%
100,000
$1,820,000 31 Dec 2020
13F
Alyeska Investment Group, L.P.
13F
Company
0.19%
99,421
$1,736,000 31 Dec 2020
13F
NORTHERN TRUST CORP
13F
Company
0.19%
98,334
$1,716,000 31 Dec 2020
13F
Verition Fund Management LLC
13F
Company
0.19%
97,066
$1,695,000 31 Dec 2020
13F
STATE STREET CORP
13F
Company
0.18%
95,018
$1,659,000 31 Dec 2020
13F
MORGAN STANLEY
13F
Company
0.18%
90,001
$1,572,000 31 Dec 2020
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
0.17%
85,400
$1,491,000 31 Dec 2020
13F
DEUTSCHE BANK AG\
13F
Company
0.14%
71,780
$1,253,000 31 Dec 2020
13F
CHARTWELL INVESTMENT PARTNERS, LLC
13F
Company
0.13%
69,108
$1,207,000 31 Dec 2020
13F
Prosight Management, LP
13F
Company
0.12%
60,250
$1,052,000 31 Dec 2020
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.12%
59,553
$1,040,000 31 Dec 2020
13F
ALPS ADVISORS INC
13F
Company
0.09%
45,910
$802,000 31 Dec 2020
13F
Invesco Ltd.
13F
Company
0.09%
44,965
$785,000 31 Dec 2020
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.08%
42,900
$749,000 31 Dec 2020
13F
Laurion Capital Management LP
13F
Company
0.08%
41,800
$730,000 31 Dec 2020
13F
CAAS CAPITAL MANAGEMENT LP
13F
Company
0.07%
36,362
$635,000 31 Dec 2020
13F
RAYMOND JAMES & ASSOCIATES
13F
Company
0.06%
33,333
$582,000 31 Dec 2020
13F
Bank of New York Mellon Corp
13F
Company
0.05%
27,570
$481,000 31 Dec 2020
13F
TUDOR INVESTMENT CORP ET AL
13F
Company
0.05%
25,000
$437,000 31 Dec 2020
13F
Nuveen Asset Management, LLC
13F
Company
0.05%
24,811
$433,000 31 Dec 2020
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.04%
23,100
$403,000 31 Dec 2020
13F
GSA CAPITAL PARTNERS LLP
13F
Company
0.04%
21,709
$379,000 31 Dec 2020
13F
Squarepoint Ops LLC
13F
Company
0.04%
21,441
$374,000 31 Dec 2020
13F
PANAGORA ASSET MANAGEMENT INC
13F
Company
0.04%
21,169
$370,000 31 Dec 2020
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.04%
19,038
$332,000 31 Dec 2020
13F
Worth Venture Partners, LLC
13F
Company
0.03%
16,420
$287,000 31 Dec 2020
13F
CITADEL ADVISORS LLC
13F
Company
0.03%
15,437
$269,000 31 Dec 2020
13F
HRT FINANCIAL LP
13F
Company
0.03%
15,024
$262,000 31 Dec 2020
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.03%
15,000
$262,000 31 Dec 2020
13F

Institutional Holders of Mirum Pharmaceuticals, Inc. - Common Stock (MIRM) as of Q1 2021

As of 31 Mar 2021, Mirum Pharmaceuticals, Inc. - Common Stock (MIRM) was held by 60 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 21,451,984 shares. The largest 10 holders included NEA Management Company, LLC, FRAZIER MANAGEMENT LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Novo Holdings A/S, Rock Springs Capital Management LP, BlackRock Inc., VANGUARD GROUP INC, BAKER BROS. ADVISORS LP, AXA S.A., and DRIEHAUS CAPITAL MANAGEMENT LLC. This page lists 60 institutional shareholders reporting positions in this security for the Q1 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2021 vs Q4 2020 Across Filers

Q4 2020 holders
71
Q1 2021 holders
60
Holder diff
-11
Investor Q4 2020 Shares Q1 2021 Shares Share Diff Share Chg % Q4 2020 Value $ Q1 2021 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.